SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+14.93%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$410M
AUM Growth
+$410M
(+20%)
Cap. Flow
+$48.6M
Cap. Flow
% of AUM
11.84%
Top 10 Holdings %
Top 10 Hldgs %
64.9%
Holding
47
New
15
Increased
13
Reduced
5
Closed
14
Top Buys
| 1 |
STJ
St Jude Medical
STJ
|
$48M |
| 2 |
KND
Kindred Healthcare
KND
|
$38.9M |
| 3 |
Eli Lilly
LLY
|
$22.3M |
| 4 |
MiMedx Group
MDXG
|
$21.9M |
| 5 |
Labcorp
LH
|
$21.3M |
Top Sells
| 1 |
Viatris
VTRS
|
$26.1M |
| 2 |
Community Health Systems
CYH
|
$23.5M |
| 3 |
Bausch Health
BHC
|
$21.5M |
| 4 |
AGN
Allergan plc
AGN
|
$18.4M |
| 5 |
Biogen
BIIB
|
$12.8M |
Sector Composition
| 1 | Healthcare | 83.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $48M | 11.69% | +733,600 | New | +$48M |
|
|
KND
2
DELISTED
Kindred Healthcare
KND
| $38.9M | 9.49% | +1,636,600 | New | +$38.9M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $34.3M | 8.37% | 551,197 +320,300 | +139% | +$20M |
|
|
NVRO
4
DELISTED
NEVRO CORP.
NVRO
| $25.1M | 6.12% | 523,736 +311,233 | +146% | +$14.9M |
|
5
Sanofi
SNY
$121B
| $23.7M | 5.78% | 479,412 -225,700 | -32% | -$11.2M |
|
|
6
Eli Lilly
LLY
$657B
| $22.3M | 5.43% | +306,500 | New | +$22.3M |
|
|
7
MiMedx Group
MDXG
$1.05B
| $21.9M | 5.33% | +2,102,059 | New | +$21.9M |
|
|
8
Labcorp
LH
$23.1B
| $21.3M | 5.19% | +169,000 | New | +$21.3M |
|
|
CNCE
9
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $16.9M | 4.12% | 1,116,100 +249,900 | +29% | +$3.78M |
|
|
ELOS
10
DELISTED
Syneron Medical Ltd
ELOS
| $13.9M | 3.39% | 1,122,900 +821,800 | +273% | +$10.2M |
|
11
Orthofix Medical
OFIX
$592M
| $12.3M | 3% | 343,201 +36,303 | +12% | +$1.3M |
|
12
Travere Therapeutics
TVTX
$1.56B
| $11.5M | 2.8% | 478,900 -156,800 | -25% | -$3.76M |
|
|
RCPT
13
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $11.3M | 2.75% | +68,400 | New | +$11.3M |
|
14
Insmed
INSM
$28.8B
| $11.2M | 2.73% | 539,107 -138,493 | -20% | -$2.88M |
|
|
MNTA
15
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.6M | 2.57% | 695,016 +111,300 | +19% | +$1.69M |
|
|
XNPT
16
DELISTED
XENOPORT, INC.
XNPT
| $10.4M | 2.53% | 1,456,900 +368,200 | +34% | +$2.62M |
|
|
SGNT
17
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $9.71M | 2.37% | 417,692 +149,392 | +56% | +$3.47M |
|
|
PMC
18
DELISTED
PharMerica Corporation
PMC
| $7.8M | 1.9% | +276,714 | New | +$7.8M |
|
19
Rigel Pharmaceuticals
RIGL
$697M
| $7.2M | 1.75% | 2,016,287 -101,700 | -5% | -$363K |
|
20
Tandem Diabetes Care
TNDM
$845M
| $7.02M | 1.71% | +555,986 | New | +$7.02M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $6.65M | 1.62% | 1,014,820 +2,400 | +0.2% | +$15.7K |
|
|
FOMX
22
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $5.26M | 1.28% | 568,549 +55,900 | +11% | +$517K |
|
|
ACT.PRA
23
DELISTED
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
| $4.96M | 1.21% | +4,900 | New | +$4.96M |
|
24
Enanta Pharmaceuticals
ENTA
$180M
| $4.73M | 1.15% | 154,300 +110,183 | +250% | +$3.37M |
|
|
AVDL
25
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.05M | 0.99% | +225,351 | New | +$4.05M |
|